Source: Tech Funding News

MPM: UK biotech AstronauTx picks 48M to advance Alzheimer's treatment

AstronauTx, a UK-based biotech startup specialising in developing treatments for Alzheimer's disease and other neurodegenerative disorders, has successfully...The post UK biotech AstronauTx picks £48M to advance Alzheimer's treatment appeared first on Tech Funding News.

Read full article »
MPM's Competitors | MPM's News | MPM's Financials
Stay up-to-date with the latest news on MPM
Est. Annual Revenue
$100K-5.0M
Est. Employees
25-100
Detlev Biniszkiewicz's photo - Managing Director of MPM

Managing Director

Detlev Biniszkiewicz

CEO Approval Rating

83/100

Read more
Stay up-to-date with the latest news on MPM